About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Tg(Col1a1-tTA)139Niss
transgene insertion 139, Robert Nissenson
MGI:3852099
Summary 3 genotypes


Genotype
MGI:5643856
cx1
Allelic
Composition
Tg(Col1a1-tTA)139Niss/0
Tg(tetO-HTR4*D100A)2Niss/0
Genetic
Background
FVB/N-Tg(Col1a1-tTA)139Niss Tg(tetO-HTR4*D100A)2Niss
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tg(Col1a1-tTA)139Niss mutation (1 available)
Tg(tetO-HTR4*D100A)2Niss mutation (1 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
growth/size/body

skeleton
• mice exhibit asymmetric enlargement of the skeleton, with progressive increase in bone accumulation starting at 3 weeks of age (J:131617)
• mice develop a fibrous dysplastic bone phenotype postnatally (J:216100)
• in some mice, the ossicles are malformed and are affected with increased bone
• massive increase in bone mineral density at 9 weeks of age
• abnormal osteocyte morphology in the canalicular network
• mice exhibit an osteosclerotic phenotype, with increased bone mineral
• marker analysis indicates defective regulation of bone remodeling in the cochlea
• marker analysis indicates disrupted perilacunar remodeling in cochlea

craniofacial
• in some mice, the ossicles are malformed and are affected with increased bone

hearing/vestibular/ear
• in some mice, the ossicles are malformed and are affected with increased bone
• mice show aggressive bony and fibrous overgrowths that surround the otic capsule and the adjacent vestibular labyrinth
• mice exhibit normal stria vascularis, organ of Corti, tunnel of Corti and intact sensorineural structures of the cochlea and no lesions involving the inner cortex of the otic capsule or centrally in the bony spiral modiolus are seen
• most, but not all, cochleae have multiple spongy, bony overgrowths involving the bulla, cochlear apex, and labyrinth
• the degree of bone lesion severity correlates with the amount of hearing loss
• the fibrodysplatic-like lesions often increase the thickness of the outer wall of the cochlea and the midmodiolar bone separating the apical scala
• highly disorganized dendritic processes and abnormal osteocyte morphology are seen in the canalicular network compared to the aligned canalicular organization in wild-type cochlea
• thicker otic capsule wall
• mice show ABR threshold elevations in response to click- and frequency-specific tone-burst stimuli at 8, 16, and 32 kHz
• increase in ABR threshold is higher in 10-12 week old mice than in 6 week old mice, indicating progressive decline in hearing
• distortion product otoacoustic emission (DPOAE) response is reduced to a level close to or below the background noise level

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
McCune Albright syndrome DOID:1858 OMIM:174800
J:216100




Genotype
MGI:5643782
cx2
Allelic
Composition
Tg(Col1a1-tTA)139Niss/0
Tg(tetO-HTR4*D100A)7Niss/0
Genetic
Background
FVB/N-Tg(Col1a1-tTA)139Niss Tg(tetO-HTR4*D100A)7Niss
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tg(Col1a1-tTA)139Niss mutation (1 available)
Tg(tetO-HTR4*D100A)7Niss mutation (1 available)
phenotype observed in females
phenotype observed in males
N normal phenotype

Skeletal abnormalities in Tg(Col1a1-tTA)139Niss/0 Tg(tetO-HTR4*D100A)7Niss/0 mice

mortality/aging
• mice show progression of the bone overgrowth, requiring euthanasia by 30 weeks of age from complications of spinal stenosis, infection or failure to thrive

growth/size/body
• mice are shorter starting at 6 weeks of age

skeleton
• mice exhibit asymmetric enlargement of the skeleton, with progressive increase in bone accumulation starting at 3 weeks of age
• mice maintained on doxycycline from conception do not develop a bone phenotype
• mice maintained on doxycycline from conception to weaning and then maintained on doxycycline-containing food exhibit normal bone phenotype
• increase in bone accrual within the skull is seen at 3 weeks of age
• increase in osteoclast number
• at 3 weeks of age, femurs show replacement of the normal long bone structures within the diaphysis by disorganized trabecular bone
• large increase in mid-diaphyseal diameter, but not femur length, at 3 weeks of age
• a moderate increase in femur size is seen at 3 weeks of age
• a large increase in femur weight is seen at 3 weeks of age
• spinal stenosis is seen by 30 weeks of age
• almost complete loss of marrow space in 9 week old mice
• bone marrow structure is disrupted, with loss of the normal bone marrow cavity in 9 week old mice
• bone marrow elements are scattered in small islands between the trabeculi
• however, red blood cell, white blood cell, and platelet counts are normal and extramedullary hematopoiesis is not seen
• mice show a 380% increase in whole-body areal bone mineral density at 9 weeks of age
• increase in total bone volume in 9 week old mice
• mice show loss of cortical bone in bony lesions
• marker analysis indicates an increase is osteoblast-lineage cells in bone lesions
• at 3 weeks of age, femurs show replacement of the normal long bone structures within the diaphysis by disorganized trabecular bone
• in 9 week old mice
• mice exhibit an osteosclerotic phenotype, with increased bone mineral
• mice show increased and disordered bone formation
• by 9 weeks of age, generalized bony lesions are seen in all mice
• bone expansion is not due to heterotopic ossification
• markers of bone turnover are increased in bony lesions

craniofacial
• increase in bone accrual within the skull is seen at 3 weeks of age

hematopoietic system
• increase in osteoclast number

immune system
• increase in osteoclast number

limbs/digits/tail
• at 3 weeks of age, femurs show replacement of the normal long bone structures within the diaphysis by disorganized trabecular bone
• large increase in mid-diaphyseal diameter, but not femur length, at 3 weeks of age
• a moderate increase in femur size is seen at 3 weeks of age
• a large increase in femur weight is seen at 3 weeks of age




Genotype
MGI:5468298
cx3
Allelic
Composition
Gt(ROSA)26Sortm1(Eif1a-tTA,tetO-mCherry/HTR4*D100A)Conk/Gt(ROSA)26Sor+
Tg(Col1a1-tTA)139Niss/0
Genetic
Background
involves: 129P2/OlaHsd * C57BL/6 * FVB/N
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gt(ROSA)26Sortm1(Eif1a-tTA,tetO-mCherry/HTR4*D100A)Conk mutation (1 available); any Gt(ROSA)26Sor mutation (944 available)
Tg(Col1a1-tTA)139Niss mutation (1 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
N
• mice not supplemented with doxycycline exhibit normal embryonic survival

skeleton





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
04/30/2024
MGI 6.23
The Jackson Laboratory